Aromatase over expression transgenic murine models for aromatase inhibitor studies
Author:
Open Access
- 2 September 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 16 (2) , 80-86
Abstract
In recent years the emerging importance of estrogen signaling in males in addition to its major role in the female reproductive system became highlighted. Aromatase is the key enzyme for synthesis of estrogens from androgens and is responsible for controlling the androgen/estrogen ratio. Inhibition of aromatase gene expression can be achieved in different ways and is important for the treatment of several estrogen-dependent diseases, such as breast cancer in females or gynecomastia/breast cancer in males, or for non-tumorigenic conditions like precocious puberty and the induction of ovulation. The inhibition of aromatase could also serve as a tool for studying the role of estrogens during development or adulthood. Using transgenic models, we are able to analyze in more detail the involvement of aromatase in the molecular mechanisms underlying the essential balance of the androgen/estrogen ratio. In this review we focus on male phenotype characterization in the aromatase overexpressing transgenic murine models and how these models can further serve as a tool for aromatase inhibitor research.Keywords
This publication has 62 references indexed in Scilit:
- New advances in ovulation inductionCurrent Opinion in Obstetrics and Gynecology, 2007
- Single-dose administration of an aromatase inhibitor for ovarian stimulationFertility and Sterility, 2005
- Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor respondersFertility and Sterility, 2002
- Aromatase Deficiency Caused by a Novel P450arom Gene Mutation: Impact of Absent Estrogen Production on Serum Gonadotropin Concentration in a BoyThe Journal of Clinical Endocrinology & Metabolism, 1999
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.Endocrine-Related Cancer, 1999
- Disruption of Sexual Behavior in Male Aromatase-Deficient Mice Lacking Exons 1 and 2 of thecyp19GeneBiochemical and Biophysical Research Communications, 1998
- Effect of Testosterone and Estradiol in a Man with Aromatase DeficiencyNew England Journal of Medicine, 1997
- Testicular cancer in nine northern european countriesInternational Journal of Cancer, 1994
- Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndromeThe Journal of Clinical Endocrinology & Metabolism, 1993
- Treatment of Precocious Puberty in the McCune–Albright Syndrome with the Aromatase Inhibitor TestolactoneNew England Journal of Medicine, 1986